Earnings calls

NEPHROPLUS concall ledger

Every earnings call for NEPHROPLUS — management tone, guidance, KPIs and promise tracking, quarter by quarter.

NEPHROPLUS · 2 transcripts · Healthcare · latest Q4 FY26

Q4 FY26Published 20 May 2026Call held 20 May 2026

NEPHROPLUS Q4 FY26 Earnings Call Transcript & Analysis

Revenue₹998.8 cr+32% YoYAdjusted EBITDA₹238.2 cr+38% YoYAdjusted EBITDA Margin23.8%Adjusted PAT₹128.3 cr+75% YoYPAT Margin12.8%

Revenue ₹999 cr (+32% YoY); Adjusted EBITDA ₹238 cr (+38% YoY); Adjusted EBITDA Margin 23.8%. FY26 Revenue grew 32% to ₹998.8 crores.

Q3 FY26Published 18 Feb 2026Call held 18 Feb 2026

Revenue₹260 cr+32% YoYAdjusted EBITDA₹63 cr+43% YoYAdjusted EBITDA Margin24.3%Adjusted PAT₹34 cr+71% YoYAdjusted PAT Margin13%

Revenue ₹260 cr (+32% YoY); Adjusted EBITDA ₹63 cr (+43% YoY); Adjusted EBITDA Margin 24.3%. Revenue for Q3 FY26 grew 32% YoY to Rs. 260 crores.